✉  info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Anti-Ageing Drugs Market Research Report Information by Drug Class (Serums and Supplements, Antioxidants and Enzymes, Stem Cells, and Drugs), by Application (Skin and Hair, Skeletal and Muscles, Age Related Disorders, and Others) by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032


ID: MRFR/Pharma/2408-CR | 260 Pages | Author: Rahul Gotadki| February 2021

Market Segmentation for Anti-Ageing Drugs Market


Anti-Ageing Drugs Drug Class Outlook (USD Billion, 2019-2030)




  • Serums And Supplements




  • Antioxidants And Enzymes




  • Stem Cells




  • Drugs




Anti-Ageing Drugs Application Outlook (USD Billion, 2019-2030)




  • Skin And Hair 




  • Skeletal And Muscles




  • Age Related Disorders




  • Others 




Anti-Ageing Drugs Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • North America Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • US Outlook (USD Billion, 2019-2030)




    • US Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • US Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others








Canada Outlook (USD Billion, 2019-2030)





    • Canada Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Canada Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others







  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Europe Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Germany Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • France Outlook (USD Billion, 2019-2030)




    • France Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • France Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • UK Outlook (USD Billion, 2019-2030)




    • UK Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • UK Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Italy Outlook (USD Billion, 2019-2030)




    • Italy Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Italy Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Other






    • Spain Outlook (USD Billion, 2019-2030)




    • Spain Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Spain Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Rest of Europe Outlook (USD Billion, 2019-2030)




    • Rest of Europe Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Rest of Europe Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Asia-Pacific Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • China Outlook (USD Billion, 2019-2030)




    • China Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • China Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Japan Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • India Outlook (USD Billion, 2019-2030)




    • India Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • India Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Australia Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • South Korea Outlook (USD Billion, 2019-2030)




    • South Korea Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • South Korea Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Rest of Asia-Pacific Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Rest of the World Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Middle East Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Africa Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Anti-Ageing Drugs by Drug Class




      • Serums And Supplements




      • Antioxidants And Enzymes




      • Stem Cells




      • Drugs






    • Latin America Anti-Ageing Drugs by Application




      • Skin And Hair 




      • Skeletal And Muscles




      • Age Related Disorders




      • Others







Research Methodology on Anti Ageing Drugs Market


Research Approach


The research approach for this research report is divided into five distinct sections, namely: 1) Literature review, 2) Development and Evaluation of the Research Model,3) Data Collection and Analysis, 4) Results and Findings and 5) Conclusion.


1. Literature review


For this research, a literature review is done to gain a holistic understanding of the Anti-ageing Drugs market. The extent of the literature reviewed is mainly focused on current market trends, emerging technologies, drivers and restraints, market segments, competitive landscape, etc. Primary sources include published reports, books and other documents and secondary sources include government reports, analyst reports newspaper and magazine articles, databases, online materials and internet resources. The findings of the literature review were used to gain an insight into the competitive dynamics of the Anti-ageing Drugs market, key opportunities and sales outlook.


2. Development and Evaluation of the Research Model


The research model for this research report is developed using PESTEL and Porter’s Five Force Analysis framework. Through PESTEL analysis, the key macro-environmental factors that affect the Anti-ageing Drugs market were identified and analysed. Alongside, Porter’s Five Forces analysis was used to determine the competitive intensity within the market, further allowing the research team to gain insight into the bargaining powers of suppliers, buyers, and the extent of competition within the market.


3. Data Collection and Analysis


The data used in this research report is collected from a variety of sources including primary and secondary sources. Primary sources include interviews with industry experts and industry stakeholders. The interviews were conducted to gain an in-depth understanding of the market dynamics, current trends, challenges, etc. Secondary sources include industry journals, newspapers, and other published documents available in the public domain. The research team also conducted an in-depth analysis of the published reports, databases such as Bloomberg, Factiva, and EDGAR.


The data collected from these different sources were analysed using both qualitative and quantitative research techniques. Statistical tools such as SPSS and EXCEL were used for analysing the data to identify trends and relationships.


4. Results and Findings


The results and findings of the research report were based on the analysis carried out on the collected data. Based on the analysis, the report provided a detailed overview of the Anti-ageing Drugs market, with an in-depth analysis of the market drivers, challenges, and opportunities. It also provided an analysis of the various market segments and a detailed view of the competitive landscape.


5. Conclusion


Based on the results and findings, the research report provided a detailed overview of the Anti-ageing Drugs market and a detailed analysis of the key market players. Further, it provided an insight into the challenges and opportunities in the Anti-ageing Drugs market. The research report concluded with a comprehensive evaluation of the market trends, segment outlook, and an outlook for the future of the Anti-ageing Drugs market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Introduction

2.1 Definition 13

2.2 Scope of Study 13

2.3 Research Objective 13

2.4 Assumptions & Limitations 14

2.4.1 Assumptions 14

2.4.2 Limitations 14

2.5 Market Structure 14

3 Research Methodology

3.1 Research Process 15

3.2 Primary Research 16

3.3 Secondary Research 16

3.4 Market Size Estimation 16

4 Market Dynamics

4.1 Drivers 18

4.1.1 Rising ageing population 18

4.1.2 Primal desire of humans to remain young 18

4.1.3 Influence of lifestyle industry and rising awareness 18

4.1.4 High levels of disposable incomes 18

4.2 Restraints 19

4.2.1 Scepticism and concerns of safety 19

4.2.2 Stringent regulations and definition ambiguity 19

4.3 Opportunities 19

4.3.1 Advancement in technologies and cellular understanding 19

4.3.2 Mergers, acquisitions and strategic alliances 20

4.4 Challenges 20

4.4.1 Steep competition 20

4.4.2 Ethical issues 20

4.4.3 Dubious and spurious products 20

5 Market Factor Analysis

5.1 Porter’s Five Force Analysis 21

5.1.1 Threat from a new entrant 22

5.1.2 Bargaining power of buyer 24

5.1.3 Bargaining power of supplier 24

5.1.4 Threat from substitute 24

5.1.5 Intensity of competitive rivalry 24

5.2 Supply Chain Analysis 25

5.2.1 Raw material 26

5.2.2 Supplier 26

5.2.3 Manufacturer 27

5.2.4 Distributer 27

5.2.5 Customer 28

5.2.6 Consumer 28

5.3 Technology Trends and Assessment 29

5.3.1 Caloric restriction mimetic drugs 29

5.3.2 Anti-oxidation strategy 29

5.3.3 Enzyme treatment 29

5.3.4 Nanotechnology 30

5.3.5 Genetics, cloning and strategies for engineered negligible senescence (SENS) 30

5.3.6 Hormonal therapy 31

5.4 Pipeline Analysis 31

5.4.1 Metformin in longevity study (MILES) 31

5.4.2 Vitamin D3 - Omega3 - Home Exercise (DO-HEALTH) 32

5.4.3 OpRegen 32

5.4.4 Study of Acarbose in Longevity (SAIL) 33

5.5 New Revenue Pockets Analysis 33

5.5.1 Introduction 33

5.5.2 New revenue segments 33

5.5.2.1 Stem cells and cell banking for future autologous cell therapies 33

5.5.2.2 Diseases related to ageing 34

5.5.2.3 Cryogenic preservation 34

5.5.2.4 Biomarkers 34

5.5.3 New revenue markets 34

6 Anti-Ageing Drugs Market, By Drug Class

6.1 Introduction 35

6.2 Serums and Supplements 37

6.3 Antioxidants and Enzymes 38

6.4 Stem Cells 39

6.5 Drugs 40

7 Anti-Ageing Market, By Application

7.1 Introduction 41

7.2 Skin and Hair 42

7.3 Skeletal and Muscles 43

7.4 Age related disorders 44

7.5 Others 45

8 Global Anti-Ageing Market, By Region

8.1 Introduction 46

8.2 North America 48

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.2.1 US 49

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.2.2 Canada 50

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3 Europe 52

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3.1 Germany 53

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3.2 France 54

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3.3 UK 55

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3.4 Italy 56

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3.5 Spain 57

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.3.6 Rest of Europe 58

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4 Asia Pacific 60

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4.1 Japan 61

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4.2 China 62

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4.3 India 63

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4.4 Australia 64

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4.5 Republic of Korea 65

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.4.6 Rest of Asia Pacific 66

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.5 Middle East and Africa 68

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.5.1 Middle east 69

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

8.5.2 Africa 70

Anti-Ageing Drugs Market, By Drug Class

Anti-Ageing Market, By Application

9 Company Profiles

9.1 Nu Skin 72

9.1.1 Company Overview 72

9.1.2 Product Overview 72

9.1.3 Financial Overview 73

9.1.4 Key Developments 74

9.1.5 SWOT 76

9.2 BIOTIME, INC. 77

9.2.1 Company Overview 77

9.2.2 Product Overview 77

9.2.3 Financial Overview 77

9.2.4 Key Developments 78

9.2.5 SWOT 79

9.3 Elysium Health Inc. 80

9.3.1 Company Overview 80

9.3.2 Product Overview 80

9.3.3 Financial Overview 80

9.3.4 Key Developments 80

9.3.5 SWOT 81

9.4 La Roche-Posay 82

9.4.1 Company Overview 82

9.4.2 Product Overview 82

9.4.3 Financial Overview 82

9.4.4 Key Developments 82

9.5 L'Oréal 83

9.5.1 Company Overview 83

9.5.2 Product Overview 83

9.5.3 Financial Overview 83

9.5.4 Key Developments 85

9.5.5 SWOT 86

9.6 DermaFix 87

9.6.1 Company Overview 87

9.6.2 Product Overview 87

9.6.3 Financial Overview 87

9.6.4 Key Developments 87

9.6.5 SWOT 88

10 MRFR Conclusion

10.1 Key Findings 89

10.1.1 From CEO’s View Point 89

10.1.2 Unmet Needs 89

10.2 Key Companies to Watch 89

11 List of Tables

TABLE 1 PIPELINE ANALYSIS 31

TABLE 2 GLOBAL ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 35

TABLE 3 GLOBAL ANTI-AGEING DRUGS MARKET FOR SERUMS AND SUPPLEMENTS BY REGION, 2020-2027 (USD MILLION) 37

TABLE 4 GLOBAL ANTI-AGEING DRUGS MARKET FOR ANTIOXIDANTS AND ENZYMES BY REGION, 2020-2027 (USD MILLION) 38

TABLE 5 GLOBAL ANTI-AGEING DRUGS MARKET FOR STEM CELLS BY REGION, 2020-2027 (USD MILLION) 39

TABLE 6 GLOBAL ANTI-AGEING DRUGS MARKET FOR DRUGS BY REGION, 2020-2027 (USD MILLION) 40

TABLE 7 GLOBAL ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 41

TABLE 8 GLOBAL ANTI-AGEING DRUGS MARKET FOR SKIN AND HAIR BY REGION, 2020-2027 (USD MILLION) 42

TABLE 9 GLOBAL ANTI-AGEING DRUGS MARKET FOR SKELETAL AND MUSCLES BY REGION, 2020-2027 (USD MILLION) 43

TABLE 10 GLOBAL ANTI-AGEING DRUGS MARKET FOR AGE RELATED DISORDERS BY REGION, 2020-2027 (USD MILLION) 44

TABLE 11 GLOBAL ANTI-AGEING DRUGS MARKET FOR OTHERS BY REGION, 2020-2027 (USD MILLION) 45

TABLE 12 GLOBAL ANTI-AGEING MARKET BY REGION, 2020-2027 (USD MILLION) 46

TABLE 13 NORTH AMERICA ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 48

TABLE 14 NORTH AMERICA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 48

TABLE 15 NORTH AMERICA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 49

TABLE 16 US ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 49

TABLE 17 US ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 50

TABLE 18 CANADA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 50

TABLE 19 CANADA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 51

TABLE 20 EUROPE ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 52

TABLE 21 EUROPE ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 52

TABLE 22 EUROPE ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 53

TABLE 23 GERMANY ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 53

TABLE 24 GERMANY ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 54

TABLE 25 FRANCE ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 54

TABLE 26 FRANCE ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 55

TABLE 27 UK ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 55

TABLE 28 U.K. ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 56

TABLE 29 ITALY ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 56

TABLE 30 ITALY ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 57

TABLE 31 SPAIN ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 57

TABLE 32 SPAIN ANTI-AGEING MARKET BY APPLICATIONS 58

TABLE 33 REST OF EUROPE ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 58

TABLE 34 REST OF EUROPE ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 59

TABLE 35 ASIA PACIFIC ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 60

TABLE 36 ASIA PACIFIC ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 60

TABLE 37 ASIA PACIFIC ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 61

TABLE 38 JAPAN ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 61

TABLE 39 JAPAN ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 62

TABLE 40 CHINA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 62

TABLE 41 CHINA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 63

TABLE 42 INDIA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 63

TABLE 43 INDIA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 64

TABLE 44 AUSTRALIA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 64

TABLE 45 AUSTRALIA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 65

TABLE 46 REPUBLIC OF KOREA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 65

TABLE 47 REPUBLIC OF KOREA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 66

TABLE 48 REST OF ASIA PACIFIC ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 66

TABLE 49 REST OF ASIA PACIFIC ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 67

TABLE 50 MIDDLE EAST AND AFRICA ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 68

TABLE 51 MIDDLE EAST AND AFRICA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 68

TABLE 52 MIDDLE EAST AND AFRICA ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 69

TABLE 53 MIDDLE EAST ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 69

TABLE 54 MIDDLE EAST ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 70

TABLE 55 AFRICA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 70

TABLE 56 AFRICA ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 71

TABLE 57 NU SKIN: KEY DEVELOPMENTS 74

TABLE 58 BIOTIME, INC.: KEY DEVELOPMENTS 78

TABLE 59 ELYSIUM HEALTH INC.:KEY DEVELOPMENTS 80

TABLE 60 L'ORÉAL :KEY DEVELOPMENTS 85

12 List of Figures

FIGURE 1 GLOBAL ANTI-AGEING DRUGS MARKET BY DRUG CLASS MARKET SHARE, 2020 (%) 11

FIGURE 2 GLOBAL ANTI-AGEING DRUGS MARKET BY APPLICATIONS MARKET SHARE, 2020 (%) 11

FIGURE 3 GLOBAL ANTI-AGEING DRUGS MARKET BY REGION MARKET SHARE, 2020 (%) 12

FIGURE 4 GLOBAL ANTI-AGING DRUGS MARKET: MARKET STRUCTURE 14

FIGURE 5 RESEARCH PROCESS OF MRFR 15

FIGURE 6 GLOBAL ANTI-AGING DRUGS MARKET: PORTER FIVE FORCES ANALYSIS 22

FIGURE 7 GLOBAL ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 36

FIGURE 8 GLOBAL ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 42

FIGURE 9 GLOBAL ANTI-AGEING MARKET BY REGION, 2020 (%) 47

FIGURE 10 NU SKIN: RECENT FINANCIALS 73

FIGURE 11 NU SKIN: GEOGRAPHICAL MIX, 2020 (%) 73

FIGURE 12 NU SKIN: BUSINESS MIX, 2020 (%) 74

FIGURE 13 NU SKIN: SWOT ANALYSIS 76

FIGURE 14 BIOTIME INC.: RECENT FINANCIALS 77

FIGURE 15 BIOTIME, INC.: SWOT ANALYSIS 79

FIGURE 16 ELYSIUM HEALTH INC.: SWOT ANALYSIS 81

FIGURE 17 L'ORÉAL: RECENT FINANCIALS 83

FIGURE 18 L'ORÉAL: GEOGRAPHIC MIX, 2020 (%) 84

FIGURE 19 L'ORÉAL: SEGMENT MIX, 2020 (%) 84

FIGURE 20 L'ORÉAL: SWOT ANALYSIS 86

FIGURE 21 DERMAFIX: SWOT ANALYSIS 88

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Press Release
pr-img
Anti-Ageing Drugs Market Multiply Relentlessly; Asserts MRFR Unleashing Industry Forecast
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
đź“ž  +1 (855) 661-4441(US)
đź“ž  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)